US4960765A
(en)
*
|
1980-03-20 |
1990-10-02 |
Farmaceutisk Laboratorium Ferring A/S |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
|
WO1981002671A1
(fr)
*
|
1980-03-20 |
1981-10-01 |
Ferring Farma Lab |
Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale
|
DE3151196A1
(de)
*
|
1981-12-23 |
1983-06-30 |
Kurt Heinz Prof. Dr. 7800 Freiburg Bauer |
Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
|
USRE33239E
(en)
*
|
1983-09-06 |
1990-06-26 |
Farmaceutisk Laboratorium Ferring A/S |
Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
|
US4657900A
(en)
*
|
1983-09-27 |
1987-04-14 |
Rowell Laboratories |
Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
|
AU1388388A
(en)
*
|
1987-04-01 |
1988-10-06 |
Dak-Laboratoriet A/S |
Benzoic acid derivatives and use thereof
|
DE3839839A1
(de)
*
|
1988-11-25 |
1990-05-31 |
Henning Berlin Gmbh |
Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen
|
US5484605A
(en)
*
|
1988-11-25 |
1996-01-16 |
Henning Berlin Gmbh Chemie-Und Pharmawerk |
Agent for treating chronically inflammatory intestinal diseases
|
GB8909559D0
(en)
*
|
1989-04-26 |
1989-06-14 |
Smith Kline French Lab |
Pharmaceutical compositions
|
US5378470A
(en)
*
|
1989-07-25 |
1995-01-03 |
Henning Berlin Gmbh |
Rectally administered pharmaceutical preparation
|
DE3924570A1
(de)
*
|
1989-07-25 |
1991-01-31 |
Henning Berlin Gmbh |
Pharmazeutische zubereitung zur rektalen verabreichung
|
SE9000485D0
(sv)
*
|
1990-02-09 |
1990-02-09 |
Pharmacia Ab |
Foamable composition for pharmaceutical use, use thereof and method of treatment
|
US5120306A
(en)
*
|
1990-03-21 |
1992-06-09 |
Gosselin Leon F |
Direct delivery of anti-inflammatories to the proximal small bowel
|
CH683965A5
(it)
*
|
1993-02-19 |
1994-06-30 |
Limad Marketing Exp & Imp |
Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
|
GB9403857D0
(en)
*
|
1994-03-01 |
1994-04-20 |
Scotia Holdings Plc |
Fatty acid derivatives
|
US20030198640A1
(en)
*
|
1994-11-07 |
2003-10-23 |
Human Genome Sciences, Inc. |
Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
|
US6551632B2
(en)
|
1997-04-01 |
2003-04-22 |
Thomas Julius Borody |
Methods and compositions for treating inflammatory bowel disease
|
PT971735E
(pt)
*
|
1997-04-01 |
2008-06-02 |
Borody Thomas J |
Métodos e composições para tratamento de doença inflamatória do intestino
|
ATE445838T1
(de)
|
2001-07-25 |
2009-10-15 |
Raptor Pharmaceutical Inc |
Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
|
DK1889198T3
(da)
|
2005-04-28 |
2015-02-09 |
Proteus Digital Health Inc |
Farma-informatiksystem
|
US7741359B2
(en)
*
|
2005-05-27 |
2010-06-22 |
Antibe Therapeutics Inc. |
Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
|
US7498355B2
(en)
*
|
2005-05-27 |
2009-03-03 |
Antibe Therapeutics Inc. |
Derivatives of 4- or 5-aminosalicylic acid
|
WO2006125293A1
(fr)
*
|
2005-05-27 |
2006-11-30 |
Antibe Therapeutics Inc. |
Derives de l'acide 4- ou 5-aminosalicylique
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
CN101489986A
(zh)
*
|
2006-06-06 |
2009-07-22 |
安泰碧治疗公司 |
曲美布汀和n-去甲基曲美布汀的盐
|
WO2008036682A2
(fr)
|
2006-09-18 |
2008-03-27 |
Raptor Pharmaceutical Inc. |
Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
|
US20100136125A1
(en)
*
|
2006-12-28 |
2010-06-03 |
Jacobus Pharmaceutical Company, Inc. |
Method of treating inflammatory bowel disease
|
US7645801B2
(en)
*
|
2007-01-29 |
2010-01-12 |
Alaven Pharmaceutical Llc |
Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
|
SI3354276T1
(sl)
|
2007-11-13 |
2020-09-30 |
Meritage Pharma, Inc. |
Sestavki za zdravljenje gastrointestinalnega vnetja
|
ES2728225T3
(es)
|
2009-02-20 |
2019-10-23 |
2 Bbb Medicines B V |
Sistema de administración de fármacos a base de glutatión
|
US8445002B2
(en)
|
2009-05-06 |
2013-05-21 |
Laboratory Skin Care, Inc. |
Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
|
WO2010144865A2
(fr)
*
|
2009-06-12 |
2010-12-16 |
Meritage Pharma, Inc. |
Procédés de traitement de troubles gastro-intestinaux
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
WO2014037832A2
(fr)
|
2012-09-06 |
2014-03-13 |
Mahesh Kandula |
Compositions et méthodes de traitement de l'épilepsie et de maladies neurologiques
|
AU2013257742A1
(en)
|
2012-05-07 |
2014-11-27 |
Cellixbio Private Limited |
Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
|
US9399634B2
(en)
|
2012-05-07 |
2016-07-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of depression
|
CA2872975A1
(fr)
|
2012-05-07 |
2013-11-14 |
Cellixbio Private Limited |
Compositions et methodes de traitement de troubles neurologiques
|
WO2013167991A1
(fr)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions et méthodes de traitement de troubles métaboliques
|
US9434704B2
(en)
|
2012-05-08 |
2016-09-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological degenerative disorders
|
WO2013168025A1
(fr)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions et méthodes de traitement des maladies de coagulation du sang
|
US9266823B2
(en)
|
2012-05-08 |
2016-02-23 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of parkinson's disease
|
WO2013167992A1
(fr)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions et méthodes de traitement de troubles inflammatoires
|
WO2013168002A1
(fr)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions et méthodes de traitement d'affections neurologiques
|
WO2013168011A1
(fr)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions et méthodes de traitement de la douleur chronique
|
US9573927B2
(en)
|
2012-05-10 |
2017-02-21 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of severe pain
|
SG11201407318UA
(en)
|
2012-05-10 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of metabolic syndrome
|
WO2013167999A2
(fr)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions et méthodes de traitement d'affections neurologiques
|
US9339484B2
(en)
|
2012-05-10 |
2016-05-17 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
|
US9242939B2
(en)
|
2012-05-10 |
2016-01-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of respiratory disorders
|
US9499527B2
(en)
|
2012-05-10 |
2016-11-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of familial amyloid polyneuropathy
|
WO2013168001A1
(fr)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions et méthodes de traitement de la douleur modérée à sévère
|
WO2013168004A2
(fr)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions et méthodes de traitement de la douleur fibromyalgique
|
WO2013168033A1
(fr)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions et methodes pour le traitement de maladies neurologiques
|
US9315478B2
(en)
|
2012-05-10 |
2016-04-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
US9394288B2
(en)
|
2012-05-10 |
2016-07-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of asthma and allergy
|
SG11201407322QA
(en)
|
2012-05-23 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of multiple sclerosis
|
US9434729B2
(en)
|
2012-05-23 |
2016-09-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
|
JP2015518855A
(ja)
|
2012-05-23 |
2015-07-06 |
セリックスビオ プライヴェート リミテッド |
粘膜炎の治療のための組成物および方法
|
US9227974B2
(en)
|
2012-05-23 |
2016-01-05 |
Cellex Bio Private Limited |
Compositions and methods for the treatment of respiratory disorders
|
CA2873096A1
(fr)
|
2012-05-23 |
2013-11-28 |
Cellixbio Private Limited |
Compositions et methodes pour le traitement d'une maladie inflammatoire de l'intestin
|
US9492409B2
(en)
|
2012-05-23 |
2016-11-15 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of local pain
|
US9108942B1
(en)
|
2014-11-05 |
2015-08-18 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
US9187427B2
(en)
|
2012-08-03 |
2015-11-17 |
Cellix Bio Private Limited |
N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
|
US9624168B2
(en)
|
2012-09-06 |
2017-04-18 |
Cellix Bio Private Limited |
Compositions and methods for the treatment inflammation and lipid disorders
|
SG11201407325YA
(en)
|
2012-09-08 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for treatment of inflammation and lipid disorders
|
US9333187B1
(en)
|
2013-05-15 |
2016-05-10 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammatory bowel disease
|
CA2914461A1
(fr)
|
2013-06-04 |
2014-12-11 |
Cellixbio Private Limited |
Compositions et procedes de traitement du diabete et du pre-diabete
|
WO2016110865A1
(fr)
|
2015-01-06 |
2016-07-14 |
Cellix Bio Private Limited |
Compositions et méthodes pour le traitement d'une inflammation et de la douleur
|
US9096537B1
(en)
|
2014-12-31 |
2015-08-04 |
Mahesh Kandula |
Compositions and methods for the treatment of mucositis
|
WO2016046835A1
(fr)
|
2014-09-26 |
2016-03-31 |
Cellix Bio Private Limited |
Compositions et méthodes de traitement de l'épilepsie et de troubles neurologiques
|
CN107207403A
(zh)
|
2014-09-29 |
2017-09-26 |
塞尔利克斯生物私人有限公司 |
用于治疗多发性硬化的组合物和方法
|
SG11201703369WA
(en)
|
2014-10-27 |
2017-05-30 |
Cellix Bio Private Ltd |
Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
|
US9173877B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of local pain
|
US9150557B1
(en)
|
2014-11-05 |
2015-10-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of hyperglycemia
|
US10208014B2
(en)
|
2014-11-05 |
2019-02-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological disorders
|
US9175008B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Prodrugs of anti-platelet agents
|
US9321716B1
(en)
|
2014-11-05 |
2016-04-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
US9284287B1
(en)
|
2014-11-05 |
2016-03-15 |
Cellix Bio Private Limited |
Compositions and methods for the suppression of carbonic anhydrase activity
|
US9290486B1
(en)
|
2014-11-05 |
2016-03-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy
|
US9932294B2
(en)
|
2014-12-01 |
2018-04-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of multiple sclerosis
|
US9206111B1
(en)
|
2014-12-17 |
2015-12-08 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological diseases
|